Meristem Family Wealth’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,382
Closed -$220K 219
2019
Q2
$220K Hold
2,382
0.07% 151
2019
Q1
$225K Buy
+2,382
New +$208K 0.08% 128
2018
Q2
Sell
-2,441
Closed -$218K 151
2018
Q1
$218K Sell
2,441
-167
-6% -$16K 0.08% 120
2017
Q4
$272K Hold
2,608
0.1% 99
2017
Q3
$380K Hold
2,608
0.15% 75
2017
Q2
$339K Hold
2,608
0.14% 76
2017
Q1
$325K Buy
2,608
+105
+4% +$12.6K 0.13% 79
2016
Q4
$290K Sell
2,503
-256
-9% -$28.5K 0.12% 83
2016
Q3
$288K Buy
2,759
+368
+15% +$39.8K 0.12% 89
2016
Q2
$236K Buy
2,391
+40
+2% +$4.14K 0.1% 94
2016
Q1
$235K Buy
2,351
+167
+8% +$17.2K 0.1% 101
2015
Q4
$262K Buy
+2,184
New +$253K 0.1% 96
2015
Q3
Sell
-2,244
Closed -$260K 116
2015
Q2
$260K Hold
2,244
0.11% 86
2015
Q1
$259K Sell
2,244
-260
-10% -$31.1K 0.11% 94
2014
Q4
$280K Sell
2,504
-1,608
-39% -$170K 0.1% 88
2014
Q3
$390K Sell
4,112
-1,000
-20% -$90.2K 0.17% 71
2014
Q2
$439K Sell
5,112
-400
-7% -$30.4K 0.18% 66
2014
Q1
$385K Sell
5,512
-956
-15% -$75.7K 0.17% 71
2013
Q4
$546K Buy
6,468
+400
+7% +$31.7K 0.22% 64
2013
Q3
$468K Buy
6,068
+168
+3% +$11.8K 0.22% 65
2013
Q2
$345K Buy
+5,900
New +$355K 0.16% 70

Other funds holding CELG

Meristem Family Wealth's CELG Position: Q3 2019 in Review

Meristem Family Wealth sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 2,382 shares — an estimated $220K sold.

Meristem Family Wealth first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $546K in Q4 2013. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Meristem Family Wealth reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Meristem Family Wealth sold 2,382 Celgene Corp shares in Q3 2019, an estimated $220K.
  • Meristem Family Wealth first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Meristem Family Wealth's Celgene Corp position peaked at $546K in Q4 2013.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Meristem Family Wealth's 13F filing for Q3 2019, filed 8 Nov 2019.